CAP President, Donald S. Karcher, MD, FCAP, discusses the future of LDTs. “The CAP still believes that the FDA is the right agency to regulate the highest-risk LDTs,” Karcher said.
For the full article click here: Looming Legal Consequences & the Future of LDTs